Organic & Biomolecular Chemistry
Communication
the mobile 22-membered supramolecular cyclic pre-transition
state to control the enantioselectivity (Fig. 2).
and X. Zhang, Chem. Rev., 2003, 103, 3029; (e) C. Moessner
and C. Bolm, Angew. Chem., Int. Ed., 2005, 44, 7564;
(f) S.-M. Lu, Y.-Q. Wang, X.-W. Han and Y.-G. Zhou, Angew.
Chem., Int. Ed., 2006, 45, 2260.
3 (a) K. B. Jensen, M. Roberson and K. A. Jørgensen, J. Org.
Chem., 2000, 65, 9080; (b) K. Funabashi, H. Ratni, M. Kanai
and M. Shibasaki, J. Am. Chem. Soc., 2001, 123, 10784;
(c) Z. Li and C.-J. Li, Org. Lett., 2004, 6, 4997; (d) S. Wang
and C. T. Seto, Org. Lett., 2006, 8, 3979; (e) C. Dubs,
Y. Hamashima, N. Sasamoto, T. M. Seidel, S. Suzuki,
D. Hashizume and M. Sodeoka, J. Org. Chem., 2008, 73,
5859.
4 (a) P. Buonora, J.-C. Olsen and T. Oh, Tetrahedron, 2001, 57,
6099; (b) T. Akiyama, H. Morita and K. Fuchibe, J. Am.
Chem. Soc., 2006, 128, 13070; (c) V. V. Kouznetsov, Tetrahe-
dron, 2009, 65, 2721; (d) G. Dagousset, J. Zhu and
G. Masson, J. Am. Chem. Soc., 2011, 133, 14804.
5 (a) M. Rueping, A. P. Antonchick and T. Theissmann,
Angew. Chem., Int. Ed., 2006, 45, 3683; (b) Q.-S. Guo,
D.-M. Du and J. Xu, Angew. Chem., Int. Ed., 2008, 47, 759;
(c) Z.-X. Jia, Y.-C. Luo and P.-F. Xu, Org. Lett., 2011, 13, 832;
(d) Z.-X. Jia, Y.-C. Luo, Y. Wang, L. Chen, P.-F. Xu and
B. Wang, Chem. – Eur. J., 2012, 18, 12958.
ð1Þ
With applications in mind, we explored the utilization of
(−)-syn-6aa and (−)-5ba-d7 in the synthesis of functionalized
drug-like compounds (+)-syn-9aa and (+)-10ba-d7 via simple
N-methylation and a click reaction, respectively (eqn (1)).10
Compounds of the type (+)-syn-9aa and (+)-10ba-d7 are
important molecules in medicinal chemistry,1 which empha-
sizes the value of the present catalytic approach to the chiral
pharmaceuticals.
6 For the selected recent reviews on the enamine-based
Michael reaction, see: (a) B. Bradshaw and J. Bonjoch,
Synlett, 2012, 337; (b) Y. Zhang and W. Wang, Catal. Sci.
Technol., 2012, 2, 42. For the selected recent papers from
ortho-substituted β-nitrostyrenes, see: (c) H. Mao, A. Lin,
Y. Tang, Y. Shi, H. Hu, Y. Cheng and C. Zhu, Org. Lett.,
2013, 15, 4062; (d) K.-S. Choi and S.-G. Kim, Eur. J. Org.
Chem., 2012, 1119; (e) D. Enders, X. Yang, C. Wang,
G. Raabe and J. Runsik, Chem. – Asian J., 2011, 6, 2255;
(f) D. Enders, G. Urbanietz and G. Raabe, Synthesis, 2011,
1905; (g) B.-C. Hong, P. Kotame and G.-H. Lee, Org. Lett.,
2011, 13, 5758; (h) D. B. Ramachary, M. S. Prasad and
R. Madhavachary, Org. Biomol. Chem., 2011, 9, 2715;
(i) B.-C. Hong, P. Kotame and J.-H. Liao, Org. Biomol.
Chem., 2011, 9, 382; ( j) D. B. Ramachary and R. Sakthidevi,
Org. Biomol. Chem., 2010, 8, 4259; (k) D. Enders, C. Wang,
X. Yang and G. Raabe, Adv. Synth. Catal., 2010, 352, 2869;
(l) D. Lu, Y. Li and Y. Gong, J. Org. Chem., 2010, 75, 6900;
(m) B.-C. Hong, P. Kotame, C.-W. Tsai and J.-H. Liao, Org.
Lett., 2010, 12, 776; (n) X. Zhang, S. Zhang and W. Wang,
Angew. Chem., Int. Ed., 2010, 49, 1481; (o) Z.-H. Yu,
H.-F. Zheng, W. Yuan, Z.-L. Tang, A.-D. Zhang and
D.-Q. Shi, Tetrahedron, 2013, 69, 8137; (p) D. B. Ramachary,
P. S. Reddy and M. S. Prasad, Eur. J. Org. Chem., 2014, DOI:
10.1002/ejoc.201402182; (q) A.-B. Xia, C. Wu, T. Wang,
Y.-P. Zhang, X.-H. Du, A.-G. Zhong, D.-Q. Xu and Z.-Y. Xu,
Adv. Synth. Catal., 2014, 356, DOI: 10.1002/adsc.201301114
and references cited therein.
In summary, we have demonstrated a novel and efficient
in situ generated chiral supramolecular assembly as the best cata-
lyst than its synthons for the asymmetric Michael reaction of
acetone with (E)-1-azido-2-(2-nitrovinyl)benzenes followed by
reductive amination to furnish the medicinally important syn-
2,4-disubstituted tetrahydroquinolines 6 with high yield, ees
and des. With the help of the ESI-HRMS technique and con-
trolled experiments, we have obtained strong evidence for the
in situ formation of proposed catalytic supramolecular assem-
bly from the organocatalysts. Readily in situ generated chiral
supramolecular assembly catalysts would become promising
future catalytic systems for more functionalized substrates
than organocatalysts.
We thank DST (New Delhi) for financial support. KSS thank
CSIR, New Delhi for her research fellowship.
Notes and references
1 (a) J. H. Rakotoson, N. Fabre, I. Jacquemond-Collet,
S. Hannedouche, I. Fouraste and C. Moulis, Planta Med.,
1998, 64, 762; (b) I. Jacquemond-Collet, S. Hannedouche,
N. Fabre, I. Fouraste and C. Moulis, Phytochemistry, 1999,
51, 1167; (c) P. J. Houghton, T. Z. Woldemariam,
Y. Watanabe and M. Yates, Planta Med., 1999, 65, 250;
(d) I. Jacquemond-Collet, J. M. Bessiere, S. Hannedouche,
C. Bertrand, I. Fouraste and C. Moulis, Phytochem. Anal.,
2001, 12, 312.
2 (a) W. S. Knowles, Angew. Chem., Int. Ed., 2002, 41, 1998;
(b) R. Noyori, Angew. Chem., Int. Ed., 2002, 41, 2008;
(c) W.-B. Wang, S.-M. Lu, P.-Y. Yang, X.-W. Han and
Y.-G. Zhou, J. Am. Chem. Soc., 2003, 125, 10536; (d) W. Tang
7 For early work on a self-assembly approach to asymmetric
catalysis, see: (a) M. L. Clarke and J. A. Fuentes, Angew.
Chem., Int. Ed., 2007, 46, 930; (b) T. Mandal and C.-G. Zhao,
Angew. Chem., Int. Ed., 2008, 47, 7714; (c) D. Uraguchi,
Y. Ueki and T. Ooi, Science, 2009, 326, 120;
This journal is © The Royal Society of Chemistry 2014
Org. Biomol. Chem., 2014, 12, 4300–4304 | 4303